The company plans to start Phase 3 study in 500 subjects in Q1 2025. Robust and durable treatment burden reduction was observed in all PRISM populations studied with the planned Phase 3 dose. The next ...

4D Molecular Therapeutics (NASDAQ:FDMT) shares are trading higher after the company released interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet age-related ...

Adam Corsetti is a Commerce Writer from the United States. An avid gamer since childhood, Adam became hooked on video games after using the original Nintendo NES console. During college, he created a ...

Volt Power Group Ltd has announced the acquisition of 4D Delta, a Perth-based leader in digital asset inspection technology and condition monitoring solutions for the mineral processing sector. This ...

Gutenberg’s printing press revolutionized the way the written word was replicated, bringing two-dimensional printing into the world and so vastly increasing accessibility of information. From that ...